Healthcare Services

Night Blindness Treatment Industry Growth Insights: Revenue Forecast to 2030

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the night blindness treatment market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Night Blindness Treatment Market reach by 2030 starting from 2026 levels?

The night blindness treatment market size has shown significant growth in recent years. It is forecast to increase from $4.2 billion in 2025 to $4.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This historical expansion can be linked to the high prevalence of malnutrition, limited access to eye care services, growing awareness of vision disorders, an increasing geriatric population, and advancements in ophthalmic diagnostics.

The night blindness treatment market is projected to experience substantial expansion in the coming years. This market is set to reach $5.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. Key factors contributing to this growth during the forecast period include greater investment in eye health initiatives, a heightened demand for tailored treatments, the broadening of gene therapy applications, advancements in healthcare infrastructure, and more favorable reimbursement policies. Significant trends anticipated in the forecast timeframe encompass an increasing occurrence of vitamin A deficiency, wider acceptance of early diagnostic methods, an uptick in minimally invasive eye surgical procedures, a growing reliance on nutritional and preventive treatments, and enhanced availability of vision care services in developing economies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18413&type=smp

Which Drivers Are Influencing Long-Term Growth In The Night Blindness Treatment Market?

The rising occurrence of cataracts is projected to boost the growth of the night blindness treatment market in the future. Cataracts are a condition where the eye’s lens becomes cloudy, leading to diminished vision. Elevated exposure to ultraviolet (UV) light from the sun, smoking, and poor dietary habits contribute to the formation of cataracts. This condition reduces the eye’s ability to distinguish between different shades of light and dark, which is essential for night vision. Consequently, this decreased contrast sensitivity makes navigating and identifying objects in low-light settings more challenging. For instance, in May 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, hospital admissions for cataract surgery in England rose to more than 516,000 in the financial year ending 2023, equivalent to 4,679 per 100,000 people, marking a significant increase from the prior year’s rate of 3,803 per 100,000. Therefore, the increasing prevalence of cataracts is driving the night blindness treatment market.

Which Segments Are Driving Activity In The Night Blindness Treatment Market?

The night blindness treatment market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Other Treatments

2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses

3) By Symptom: Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms

4) By End User: Clinic, Hospital, Other End Users

Subsegments:

1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications

2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery

3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

Which Trends Are Expected To Influence The Night Blindness Treatment Market In The Upcoming Years?

Major entities within the night blindness treatment market are actively developing advanced genetic therapies. These innovations aim to address the root genetic mutations responsible for the condition, thereby enhancing treatment efficacy and leading to improved patient outcomes. Genetic therapies work by specifically targeting and repairing genetic mutations that compromise retinal function, offering the potential to restore vision in individuals afflicted with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, unveiled HG004. This gene therapy is specifically designed for inherited retinal diseases, including Leber’s congenital amaurosis. Preclinical studies have demonstrated that this therapy is superior to existing treatments, with the goal of restoring retinal function and alleviating night blindness and other conditions associated with RPE65-induced impairments.

Which Key Market Players Are Investing In Expansion And Innovation Within The Night Blindness Treatment Market?

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann-La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report

Which Regions Are Projected To Dominate The Night Blindness Treatment Market In The Coming Years?

North America was the largest region in the night blindness treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Night Blindness Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18413&type=smp

Browse Through More Reports Similar to the Global Night Blindness Treatment Market 2026, By The Business Research Company

Optic Nerve Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Retinal Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Night Vision Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/night-vision-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795